Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 2/20 | 0.32 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.31 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.31 |
| ▸ | RAPGEF3 | O95398 | 1/20 | 0.31 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.31 |
| ▸ | XDH | P47989 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19912412 | 0.96 | KIF11 (0.34) | TSHRSMN1; SMN2ARKIF11 | |
| SCHEMBL19912410 | 0.96 | KIF11 (0.32) | TSHRSMN1; SMN2KIF11 | |
| SCHEMBL19903496 | 0.93 | RAPGEF3 (0.35) | TSHRSMN1; SMN2ARCSNK1DCSNK1G2 | |
| SCHEMBL19912425 | 0.93 | KIF11 (0.36) | TSHRSMN1; SMN2ARXDHKIF11 | |
| SCHEMBL19917907 | 0.92 | KIF11 (0.38) | TSHRSMN1; SMN2ARXDHKIF11 | |
| SCHEMBL19912387 | 0.91 | AR (0.35) | TSHRSMN1; SMN2ARKIF11 | |
| SCHEMBL19912407 | 0.91 | KIF11 (0.38) | ARKIF11 | |
| SCHEMBL22822506 | 0.90 | RXRA (0.36) | TSHRSMN1; SMN2CSNK1DCSNK1G2RAPGEF3 | |
| SCHEMBL19912570 | 0.90 | KIF11 (0.34) | TSHRSMN1; SMN2ARXDHKIF11 | |
| SCHEMBL19918034 | 0.89 | KIF11 (0.36) | ARRAPGEF3RAPGEF4KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9917270-B1 | Organic electroluminescent device having an exciton quenching layer | CYNORA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | TSHR 2400/4885SMN1; SMN2 4419/4885AR 4212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.